GenoFocus is a platform technology company developing enzyme solutions for specialty food, eco-friendly process, biopharmaceuticals, cosmeceuticals and agriculture. We develop enzymes through molecular evolution using smart library generation and microbial display-based high throughput screening. With fungal and bacterial secretion systems, we custom-produce the evolved enzymes in large scale fermentation and down-stream process.

Business Category

Bio-materials, Cosmetics ingredient, Food ingredient etc.

Key Partners

Korea Research Institute of Bioscience and Biotechnology etc.

Company Competency

Industrial Enzymes R&D and Production

Nutraceutical Supplement R&D and Production

Bio-materials for cosmetics R&D and Production

Pipeline

Lactase, Catalase, Lipase etc.

Researching and Developing Microbiome drugs for Wet-AMD, IBD, etc.

Major Performance

2020. 08 Received Self-Affirmed GRAS status for SOD, Superoxide Dismutase, from US FDA

2017. 03 Acquired Sungwun Bio Inc.

2016. 11 Received GRAS no objection letter for Lactase from US FDA

2015. 09 Lactase supply contract with Company L

2013. 08 Launched Katalse S 350L for decomposing H2O2 used in semiconductor process

2008. 11 NDA with world-class pharmaceutical company: Optimized lipase for production of next generation anticonvulsant durg

2001. 05 Designated as National Research Laboratory to develop ‘Microbial Display Technology’

Key Products

GF B SOD (Superoxide Dismutase)

Gfzyme Proteinase K

Certified /Permission

Innobiz

Research Institutes

ISO9000

Venture

FSSC22000